Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.

@article{Strik2000EfficacyAS,
  title={Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.},
  author={Jacqueline J M H Strik and A Honig and Richel H. B. Lousberg and Aimee Lousberg and Emile C. Cheriex and Hanneke G Tuynman-Qua and Petra M J C Kuijpers and Hein J. J. Wellens and Herman M. van Praag},
  journal={Psychosomatic medicine},
  year={2000},
  volume={62 6},
  pages={783-9}
}
OBJECTIVE Depression and hostility are significant risk factors for mortality and morbidity after myocardial infarction (MI). Much research is still needed to identify effective ways to reduce emotional distress in patients with cardiovascular disease. This double-blind, placebo-controlled study investigated the efficacy and safety of the antidepressant… CONTINUE READING